From June 8 to 12, our team had the honor of attending the ISHAS Congress, held this year in Illinois, USA.
This world-renowned event, organized every two years, brings together the global scientific community focused on Hyaluronic Acid. It is recognized for its exceptionally high level of academic and clinical content, with a strong emphasis on research, innovation, and scientific progress.
We were proud to contribute to the program with a speaking engagement, and to share the stage with top international experts in the field. It was a valuable opportunity to present our insights, exchange with peers, and stay at the forefront of scientific advancement.
We’re already looking forward to the next edition of this outstanding congress.
From 17 February, we celebrate the Lunar New Year and step into the Year of the Fire Horse — a powerful symbol of drive, resilience, and forward momentum across Asia.
A time of renewal, ambition, and fresh opportunities for growth.
HTL Biotechnology took part in IMCAS 2026, one of the leading international congresses dedicated to aesthetic medicine and dermatology. This major event was an opportunity to highlight the company’s strategy, innovations, and commitment to advancing regenerative medicine through high-performance biopolymers.
HTL Biotechnology is recognized for the second consecutive year among France’s most dynamic and innovative mid-sized companies.